DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Sumitomo Chemical India Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·6 Oct 2026, 5:59 am

Sumitomo Chem India

Sumitomo Chemical India Limited has informed stock exchanges that it has obtained a certificate under SEBI’s Depositories and Participants Regulations, 2018. This document confirms that the company has complied with all necessary regulations for its shareholding pattern and depository operations. It serves as an official confirmation of its adherence to corporate governance standards.

For investors, this development is a routine regulatory milestone rather than a significant market event. It ensures that the company’s shareholding structure is transparent and fully compliant with SEBI rules. This transparency is a positive signal for maintaining trust in the company's operations and financial reporting.

Investors should monitor the company’s future quarterly results and any updates regarding its compliance status. While this news itself does not alter the stock's fundamental value, it reinforces the company's commitment to regulatory adherence. Keeping an eye on broader market trends and the chemical sector's performance will be key for the next steps.